ORTH Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Ortho Regenerative Technologies Insider Trading History Chart

This chart shows the insider buying and selling history at Ortho Regenerative Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ortho Regenerative Technologies Share Price & Price History

Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 07/3/2020 01:00 AM ET

This chart shows the closing price history over time for ORTH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Ortho Regenerative Technologies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/23/2021Guy Paul AllardSenior OfficerBuy8,775$0.48$4,212.00122,250
8/20/2021Luc MainvilleSenior OfficerBuy50,000$0.46$22,750.00956,000
See Full Table

SEC Filings (Institutional Ownership Changes) for Ortho Regenerative Technologies (CNSX:ORTH)

Ortho Regenerative Technologies logo
Ortho Regenerative Technologies Inc., an orthopedic and sports medicine technology company, engages in researching and developing novel therapeutic tissue repair devices to enhance the success rate of sports medicine surgeries in Canada. The company develops Ortho-R, a freeze-dried formulation for the treatment of rotator cuff tears; and Ortho-M, a freeze-dried formulation for the treatment of meniscus tears that are under the large animal studies. It also develops Ortho-C, a freeze-dried matrix for the treatment of articular cartilage; and Ortho-V, a freeze-dried biopolymer for the prevention of osteoarthritis pain that are under the feasibility studies. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.
Read More on Ortho Regenerative Technologies

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

2,500 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A